Breakthrough symptoms after switching long-acting injectable paliperidone palmitate from the gluteal to the deltoid site of administration.
From the Department of Psychiatry, University of British Columbia, Vancouver, BC (Procyshyn, Barr, Honer); the British Columbia Mental Health and Addictions Research Institute, Vancouver, BC (Procyshyn, Honer); the Grey Nuns Hospital, Edmonton, AB (Banasch); and the Department of Anesthesiology, Pharmacology & Therapeutics, University of British Columbia, Vancouver, BC (Barr).
Ric M
RM
Procyshyn
From the Department of Psychiatry, University of British Columbia, Vancouver, BC (Procyshyn, Barr, Honer); the British Columbia Mental Health and Addictions Research Institute, Vancouver, BC (Procyshyn, Honer); the Grey Nuns Hospital, Edmonton, AB (Banasch); and the Department of Anesthesiology, Pharmacology & Therapeutics, University of British Columbia, Vancouver, BC (Barr).
Jan L
JL
Banasch
From the Department of Psychiatry, University of British Columbia, Vancouver, BC (Procyshyn, Barr, Honer); the British Columbia Mental Health and Addictions Research Institute, Vancouver, BC (Procyshyn, Honer); the Grey Nuns Hospital, Edmonton, AB (Banasch); and the Department of Anesthesiology, Pharmacology & Therapeutics, University of British Columbia, Vancouver, BC (Barr).
Alasdair M
AM
Barr
From the Department of Psychiatry, University of British Columbia, Vancouver, BC (Procyshyn, Barr, Honer); the British Columbia Mental Health and Addictions Research Institute, Vancouver, BC (Procyshyn, Honer); the Grey Nuns Hospital, Edmonton, AB (Banasch); and the Department of Anesthesiology, Pharmacology & Therapeutics, University of British Columbia, Vancouver, BC (Barr).
William G
WG
Honer
D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics; D003692:Delayed-Action Preparations / Q000008:administration & dosage / Q000493:pharmacokinetics; D006212:Hallucinations / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D000068882:Paliperidone Palmitate / Q000008:administration & dosage* / Q000493:pharmacokinetics; D012559:Schizophrenia / Q000188:drug therapy*
D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations; D000068882:Paliperidone Palmitate